CSNK1A1 and colorectal cancer: Critically, an absence of CK1α and/or MDM4 is p53 activating (Wei et al., 2016) and high CK1α activity would be anticipated to be oncogenic, which is in keeping with recent findings demonstrating CK1α overexpression correlates with poor survival in colorectal cancer (Richter et al., 2018).